decitabine · Injection, Powder, Lyophilized, For Solution

What changed in the last 90 days

Every detected change for decitabine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Nucleoside Metabolic Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• pentostatin· in shortage
• azacitidine· in shortage
• (daunorubicin and cytarabine) liposome· 1 maker
• azacitidine for· 1 maker
• fluorouracil cream, 0.5%· 1 maker
• gemcitabine intravesical· 1 maker
• purixan· 1 maker
• trifluridine and tipiracil· 1 maker
• cedazuridine and decitabine· 3 makers
• trifluridine· 6 makers
• mercaptopurine· 7 makers
• cytarabine· 9 makers

Common questions

Is Decitabine in shortage right now?

No. FDA does not currently list Decitabine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Decitabine?

31 companies have marketed Decitabine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

• Planned discontinuation — Decitabine, Injection, 50 mg (NDC 68001-573-41)Feb 20, 2026